BrainsWay To Invest Up To $2.5M In BrainStim Health

Under the terms of the agreement, BrainsWay will invest $1.0 million initially, with potential for an additional $1.5 million via two milestone-based investments, for a minority position in BrainStim in the form of a preferred, annually compounding security. The agreement also provides for a redemption mechanism relating to the shares.